Masimo Corporation (MASI)
Market Cap | 7.02B |
Revenue (ttm) | 2.05B |
Net Income (ttm) | 81.50M |
Shares Out | 52.91M |
EPS (ttm) | 1.51 |
PE Ratio | 88.37 |
Forward PE | 38.41 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 330,427 |
Open | 133.00 |
Previous Close | 132.68 |
Day's Range | 132.43 - 134.14 |
52-Week Range | 75.22 - 198.00 |
Beta | 0.95 |
Analysts | Hold |
Price Target | 127.80 (-4.23%) |
Earnings Date | May 7, 2024 |
About MASI
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional... [Read more]
Financial Performance
In 2023, Masimo's revenue was $2.05 billion, an increase of 0.60% compared to the previous year's $2.04 billion. Earnings were $81.50 million, a decrease of -43.21%.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for MASI stock is "Hold." The 12-month stock price forecast is $127.8, which is a decrease of -4.23% from the latest price.
News
Masimo to Present in 45th Annual Raymond James Institutional Investors Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 45th Annual Raymond James Institutional Investors Conference on Tuesday, March 5, 202...
Masimo Reports Fourth Quarter and Full-Year 2023 Financial Results
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended December 30, 2023. Fourth Quarter 2023 Results: Consolidated rev...
Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth
IRVINE, Calif. & DENVER--(BUSINESS WIRE)--Masimo and UCHealth are entering into a strategic collaboration to improve patient care using the latest in virtual care and telehealth capabilities.
New Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion
IRVINE, Calif.--(BUSINESS WIRE)--A new study has found that Masimo RD SET® pulse oximetry sensors accurately measure SpO2 on both Black and White subjects even when perfusion is low.
Masimo CEO: Would Be Happy With Win-Win Apple Settlement
Apple will begin selling versions of its Series 9 and Ultra 2 watches without a blood oxygen feature in the US, following a legal setback in its patent dispute with Masimo. Masimo CEO Joseph Kiani joi...
Masimo Announces Reinstatement of Import Ban on Infringing Apple Watches
IRVINE, Calif.--(BUSINESS WIRE)--The Federal Circuit has lifted the temporary stay on the import ban of certain Apple Watch models.
Ex-Disney Chief Bob Chapek Appointed To Board Of Medical Firm Masimo As Company Battles Apple
Bob Chapek, a nearly three-decade Disney veteran who was ousted in 2022 as the media company's CEO, has been appointed to the board of directors of medical tech firm Masimo. The move comes during a dr...
Masimo Announces New Member of the Board of Directors
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that Bob Chapek has been appointed to Masimo's Board of Directors. Mr. Chapek was Chief Executive Officer of The Walt Disney Comp...
U.S. appeals court upholds tribunal decisions in Apple-Masimo patent dispute
A U.S. appeals court on Friday upheld two earlier decisions by a patent tribunal that favored Masimo in its intellectual property dispute with Apple over blood oxygen sensors in newer Apple Watch mode...
Masimo Announces Select Preliminary 2023 Financial Results and 2024 Guidance
IRVINE, California--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended December 30, 2023 and provided es...
Can Apple and Masimo Settle Their Differences?
Nicholas Matich, an intellectual property lawyer and former acting general counsel of the United States Patent and Trademark Office, explains how he thinks Apple's patent dispute with Masimo will play...
Masimo CEO Addresses Smartwatch Patent Dispute With Apple
Masimo CEO Joe Kiani says Apple should apologize for copying his company's patented technology for measuring blood-oxygen levels in Apple's smartwatches. A US import ban on certain Apple Watches is se...
Masimo CEO on Apple patent dispute: We are the rightful creator and inventor of this technology
Joe Kiani, Masimo CEO, joins 'Closing Bell: Overtime' to discuss Apple pausing some Watch sales due to a patent dispute.
Masimo Receives FDA Clearance for Stork™ Baby Monitoring System
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Stork™, a revolutionary baby monitoring system, has received FDA clearance for prescription use to continuously monitor babies at home.
New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation
NEUCHATEL, Switzerland--(BUSINESS WIRE)--In the largest study of Masimo ORi™ to date, researchers found a significant correlation between ORi and PaO2 during one-lung ventilation.
Masimo to Present in Piper Sandler 35th Annual Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023 at 9:...
Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use
IRVINE, Calif.--(BUSINESS WIRE)--The Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter and prescription use.
Masimo to Present in Jefferies London Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Wednesday, November 15, 2023 at 3:00 pm GMT...
GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform
CHICAGO & IRVINE, Calif.--(BUSINESS WIRE)--GE HealthCare and Masimo announced a joint agreement to integrate Masimo SET® into the GE HealthCare Portrait Mobile platform.
Masimo Reports Third Quarter 2023 Financial Results
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced its financial results for the third quarter of 2023, ended September 30, 2023. Third Quarter 2023 Financial Results C...
United States International Trade Commission Issues Exclusion Order for Infringing Apple Watches, Finding that Apple Violated U.S. Trade Laws
WASHINGTON--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that the United States International Trade Commission (USITC) has recommended a limited exclusion order for infringing Apple Watches ...
Apple responds to Masimo patent dispute over smart watches
Apple puts out statement in response to a International Trade Commission ruling that claims it violated patent law concerning its smart watches.
Masimo to Report Third Quarter 2023 Financial Results after Market Close on Tuesday, November 7
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release third quarter 2023 financial results for the period ended September 30, 2023, after the market closes on Tuesday, November 7, 2023. ...
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Masimo Investors of a Lead Plaintiff Deadline of October 23, 2023
NEW YORK , Oct. 23, 2023 /PRNewswire/ -- Attention Masimo Corporation ("Masimo") (NASDAQ: MASI) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on beha...
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Masimo Corporation with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 23, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Masimo Corporation ("Masimo" o...